Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
NRG Oncology
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
OHSU Knight Cancer Institute
Northwestern University
Mayo Clinic
National Cancer Institute (NCI)
National Cancer Institute (NCI)